| Title : From bench to brain: novel thieno-oxazine hybrids as potent pleiotropic anti-Alzheimer's agents with in vivo\/in vitro validation and in silico insights - Fayed_2026_J.Enzyme.Inhib.Med.Chem_41_2598741 |
| Author(s) : Fayed EA , M AAN , Oudah KH , Ebrahim MA , Gohar NA , Abu-Elfotuh K , Khedre Mohamed E , Hamdan AME , Albalawi NA , Faisal Alzahrani S , Hamdan AM , Almotairi R , Hafez SM , Ramsis TM |
| Ref : J Enzyme Inhib Med Chem , 41 :2598741 , 2026 |
|
Abstract :
Due to their various pharmacological effects, several substituted sulphur heterocycles containing thiophene have recently attracted a great deal of attention. A novel 2,3-diaryl-2,3,5,6,7,8-hexahydro-4H-benzo[4,5]thieno[3,2-e][1,3]oxazin-4-one (9-14) was synthesised starting from cyclohexa[b]thiophene. Compounds 9 and 10 showed the greatest gene expression downregulation of BAX by 75.1% and 79.7%, and upregulation of Bcl-2 gene expression by 8.1 folds for each. It also decreased the level of AChE by 70.2 and 75%; respectively. Compounds 9 and 10 significantly increased Wnt3a levels by 5.8 and 6.6 folds, and beta-Catenin levels by 10.1 and 10.5 folds, respectively, compared to donepezil. They significantly downregulated 5-GSK3beta gene expression by 77.1%, and 78.7%, respectively. Even though all compounds exhibited potent inhibition of AChE, all synthesised compounds, except for compounds 5 and 11 demonstrated higher selectivity towards BChE (SI < 1). In-silico ADMET calculations as well as molecular docking have been performed for synthetic compounds. |
| PubMedSearch : Fayed_2026_J.Enzyme.Inhib.Med.Chem_41_2598741 |
| PubMedID: 41481412 |
Fayed EA, M AAN, Oudah KH, Ebrahim MA, Gohar NA, Abu-Elfotuh K, Khedre Mohamed E, Hamdan AME, Albalawi NA, Faisal Alzahrani S, Hamdan AM, Almotairi R, Hafez SM, Ramsis TM (2026)
From bench to brain: novel thieno-oxazine hybrids as potent pleiotropic anti-Alzheimer's agents with in vivo\/in vitro validation and in silico insights
J Enzyme Inhib Med Chem
41 :2598741
Fayed EA, M AAN, Oudah KH, Ebrahim MA, Gohar NA, Abu-Elfotuh K, Khedre Mohamed E, Hamdan AME, Albalawi NA, Faisal Alzahrani S, Hamdan AM, Almotairi R, Hafez SM, Ramsis TM (2026)
J Enzyme Inhib Med Chem
41 :2598741